Füst G, Medgyesi G A, Rajnavölgyi E, Csécsi-Nagy M, Czikora K, Gergely J
Immunology. 1978 Dec;35(6):873-84.
Different immunoglobulin preparations of human monoclonal IgM, normal human and rat IgG, as well as purified rabbit antibodies were treated by various methods, fragmentation, aggregation and complexing with antigen. The ability of the treated and untreated preparations to fix isolated human C1, to activate the classical complement pathway (to consume C4 in normal human serum) were compared. It was found that the different methods affected the conformation of the immunoglobulin molecules in different ways and induced changes to a greater or lesser extent in the two capacities of the preparations tested. In the case of the monoclonal IgM preparation a strong C1-fixation was observed without measurable complement activation. Other preparations, interfacially aggregated human IgG, BSA-anti-BSA and OA-anti-OA immune complexes had a very weak C1-fixing but a marked complement activating capacity. Some preparations, e.g. heat-aggregated IgG, both fixed and activated C1 effectively, aggregates with a complement-activating capacity without C1-fixing effect were separated by gel-filtration. It was demonstrated further, that at a given time only a part of the activated C1 molecules could be found fixed to the immunoglobulins, the other part was released into the fluid phase after activation. On the basis of the results of this and previous studies a hypothesis is proposed suggesting three possible results of the interaction between C1 and the different preparations: (1) firm fixation and activation; (2) binding not followed by activation and (3) a transient binding leading to activation. The possible application of this hypothesis for the interpretation of the results of the different methods for detecting immune complexes is discussed.
对人单克隆IgM、正常人及大鼠IgG的不同免疫球蛋白制剂,以及纯化的兔抗体采用多种方法进行处理,包括片段化、聚集以及与抗原复合。比较了处理前后制剂固定人C1分离物、激活经典补体途径(消耗正常人血清中的C4)的能力。发现不同方法以不同方式影响免疫球蛋白分子的构象,并在不同程度上引起受试制剂的这两种能力发生变化。就单克隆IgM制剂而言,观察到其有很强的C1固定能力,但无明显的补体激活。其他制剂,如界面聚集的人IgG、牛血清白蛋白-抗牛血清白蛋白和卵清蛋白-抗卵清蛋白免疫复合物,C1固定能力很弱,但补体激活能力显著。一些制剂,如热聚集IgG,既能有效固定C1又能激活C1,通过凝胶过滤分离出具有补体激活能力但无C1固定作用的聚集物。进一步证明,在给定时间,仅能发现一部分激活的C1分子固定在免疫球蛋白上,另一部分在激活后释放到液相中。基于本研究及先前研究的结果,提出一个假说,表明C1与不同制剂相互作用可能产生三种结果:(1)牢固固定并激活;(2)结合但不激活;(3)短暂结合导致激活。讨论了该假说在解释检测免疫复合物不同方法结果方面的可能应用。